For GBM, key genetic changes include mutations or dysregulations in the epidermal growth factor receptor (EGFR), TP53, phosphatase and tensin homolog (PTEN), telomerase reverse transcriptase (TERT), and O-6-methylguanine-DNA methyltransferase (MGMT). This evidence concerns the gene PTEN and glioblastoma.